These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 576852)

  • 1. Treatment of mild hypertension. Preliminary results of a two-year feasibility trial.
    Perry HM
    Circ Res; 1977 May; 40(5 Suppl 1):I180-7. PubMed ID: 576852
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension. Prepared for the Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension.
    Ann N Y Acad Sci; 1978 Mar; 304():267-92. PubMed ID: 360921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
    Channick BJ; Kessler WB; Marks AD; Adlin EV
    Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results obtained in the treatment of permanent arterial hypertension with a combination of reserpine and a "thiazide" diuretic].
    Domart A; Fillastre JP
    Presse Med (1893); 1965 Oct; 73(43):2423-5. PubMed ID: 5830175
    [No Abstract]   [Full Text] [Related]  

  • 5. [The association of chlorthalidone and reserpine in the therapy of essential arterial hypertension].
    Forin G; Permutti B
    Minerva Med; 1969 Feb; 60(15):662-6. PubMed ID: 5774384
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of essential hypertension with hygroton-reserpine].
    Gómez Francisco A
    Hisp Med; 1965 Jun; 22(252):359-71. PubMed ID: 5843526
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prolonged treatment of arterial hypertension of arteriosclerotic origin with a combination of chlorthalidone and reserpine].
    Grimaldi MG
    Clin Ter; 1967 Mar; 40(6):533-63. PubMed ID: 5601194
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical observations on the hypotensive action of the association of chlorthalidone and reserpine].
    Chiaverini P; Dalli G
    Minerva Med; 1967 Dec; 58(100):4578-84. PubMed ID: 6081721
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical study on the hypotensive action of a chlorthalidone-reserpine association.
    Strata A; Salvatore V
    Panminerva Med; 1966 Apr; 8(4):113-20. PubMed ID: 5329329
    [No Abstract]   [Full Text] [Related]  

  • 11. [New theories and clinal demonstratioof the activity and usefulness of chlorthalidone-reserpine in the treatment of hypertensive diseases].
    Pinacci U; Guida B
    Minerva Cardioangiol; 1968 Feb; 16(2):139-48. PubMed ID: 5736318
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the antihypertensive efficacy of acebutolol, chlorthalidone and the combination of acebutolol and chlorthalidone in the treatment of mild and moderate primary arterial hypertension].
    Del Nero Júnior E; Lima EV; Savioli RM; de Rezende MC
    Arq Bras Cardiol; 1983 May; 40(5):357-61. PubMed ID: 6360100
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
    Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the anti-hypertensive action of the chlorthalidone-reserpine combination. Clinical contribution].
    Avanzi G
    Minerva Med; 1965 Dec; 56(99):4358-65. PubMed ID: 5323493
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of the effect of verapamil in hypertensive patients].
    Gelman A; de Albuquerque EM; Reynaldo Stella S; Draibe SA; Ajzen H
    Arq Bras Cardiol; 1983 Jan; 40(1):69-71. PubMed ID: 6351814
    [No Abstract]   [Full Text] [Related]  

  • 16. Elderly hypertensive patient. Epidemiologic review.
    Spotnitz HM
    N Y State J Med; 1978 Jun; 78(7):1125-9. PubMed ID: 351467
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experimentation with Hygroton-reserpine (apropos of 58 cases)].
    Warembourg H; Delomez M
    Lille Med; 1966 Jan; 11(1):72-5. PubMed ID: 5903756
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN
    Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chlorthalidone at low doses in the treatment of mild and moderate hypertension: analysis of efficacy, hypokalemia frequency and cardiac rhythm disorders].
    Plavnik FL; Ribeiro AB; Maranhão MF; Nusbaum IM; Kohlmann Júnior O
    Arq Bras Cardiol; 1988 Feb; 50(2):135-8. PubMed ID: 3063238
    [No Abstract]   [Full Text] [Related]  

  • 20. Chlorthalidone in the long term therapy of patients with hypertension.
    Thomson AE
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):21-5. PubMed ID: 5440313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.